+86-571-8627 3270
CHONGQING HOLLYPHARM CO.,LTD
38 YRS
Chongqing City, China
CNY 75.5 Million
167166 m²
100-500 people
Main Products: Artemisinin / Artemether / Artesunate / Dihydroartemisinin
Chongqing City, China
VERIFIEDMANUFACTURINGCOMPANY
Business Type
Manufacturing
Total Employees
100-500 People
Plant Size
251 Acres
Production Experience
38+ Years
Registered Capital
CNY 75.5 Million
MAIN
PRODUCTS
More
Artemisinin
CAS: 63968-64-9
Packing: 25 KG/Fibre Drum
Lead Time: 30-60 days
Inquiry
Artemether
CAS: 71963-77-4
Packing: 25 KG/Fibre Drum
Lead Time: 14-30 days
Inquiry
Artesunate
CAS: 88495-63-0
Packing: 25 KG/Fibre Drum
Lead Time: 14-30 days
Inquiry
ABOUT US
CHONGQING HOLLYPHARM CO.,LTD
Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. (hereinafter referred to as kunyao Wulingshan) has a registered capital of 75.5 million yuan, covers an area of 251 Mu and has 190 production technicians. It is a modern pharmaceutical enterprise with pharmaceutical R & D, production and sales as its core business. Founded in December 1986, it was restructured from the former Chongqing Wulingshan pharmaceutical factory into a wholly-owned subsidiary of Kunming Pharmaceutical Group in April 2001. Since its establishment, with the strong support of governments at all levels and Kunming Pharmaceutical Group, the company's business has developed rapidly and its comprehensive strength has been continuously improved. It has won many honorary titles, such as "national high-tech enterprise", "Chongqing leading enterprise of agricultural industrialization", "Chongqing contract abiding and trustworthy enterprise", "Chongqing excellent private enterprise", "Chongqing civilized unit" and so on. In recent years, the company has continuously increased investment in independent R & D, actively introduced technology and talents, and worked closely with well-known authoritative domestic scientific research institutes to obtain 25 domestic invention patents and utility new patents. The company's scientific research center is a municipal (provincial) enterprise technology center. The company mainly produces and sells artemisinin, dihydroartemisinin, artemether, artesunate, Maqin cough syrup and hesperidin. The annual production capacity of artemisinin and its derivatives is 90 tons, 12 million boxes of syrup and 1000 tons of hesperidin. The production quality control system has been inspected and recognized by the World Health Organization, and has also passed the on-site PQ certification inspection of the World Health Organization. Adhering to the advanced corporate culture concept of Kunming Pharmaceutical Group and the mission of "green Kunming Pharmaceutical and well-being society", the company actively promotes pharmaceutical products with high scientific and technological content and advanced health concept to the domestic and international markets. Continuously innovate the management concept and marketing mode, strengthen customer strategic cooperation, resource sharing, mutual benefit and win-win, and are determined to become an innovative pharmaceutical enterprise with sustainable competitiveness.
View More
MANUFACTURING CAPABILITY & EHS
Testing Device
HPLC
GC
UV
AAS
AFS
MS
Conductivity meter
EHS
Self-treatment
Emergency measure
COMPANY INTRODUCTION
Nearest Port
Shanghai Port
Nearest Airport
Chongqing Jiangbei International Airport
Nearest Key City
Wuhan
Distance to Key City
748KM
Factory Gate
Factory Office
Activity
Others
Others
Others
Others
Others
Others
TELL US WHAT YOU NEED
*
*
*
*
Submit Requirement
CONTACT US
CHONGQING HOLLYPHARM CO.,LTD
Manager Yang(Sales Manager)
0086-571-8627 3270
108 Jinyuan Avenue South Road, Banxi light industrial park, Youyang Tujia and Miao Autonomous County, Chongqing suburb
Send Email
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >